FIELD: medicine, virology, molecular biology, genetic engineering.
SUBSTANCE: invention relates to nucleic acid constructions and to vaccine preparations containing such construction and to using such preparations in medicine. Nucleotide sequence that encodes HIV-1 gag protein or its fragment containing gag epitope and HIV-1 Nef protein or its fragment containing nef epitope, and RT protein or its fragment containing RT epitope is coupled operatively with heterologous promoter wherein gag sequence is optimized by cordons. This sequence is a component of pharmaceutical composition and used in treatment and/or prophylaxis of HIV-infection and AIDS.
EFFECT: valuable medicinal properties of constructions, protein and pharmaceutical composition.
15 cl, 50 dwg, 22 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2648791C2 |
IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2721274C2 |
VACCINE AGAINST HIV/AIDS | 2010 |
|
RU2475264C2 |
CR3 CHIMERA GENE AND CR3 CHIMERA PROTEIN ENCODED THEREWITH (VARIANTS) INDUCING ANTI-HIV-1 IMMUNE RESPONSE | 2002 |
|
RU2302461C2 |
HIV VACCINE BASED ON MAXIMISED Gag AND Nef TARGETING ON DENDRITE CELLS | 2009 |
|
RU2539765C2 |
COMPOSITIONS AND METHODS OF GENETIC MATERIAL DELIVERY | 1994 |
|
RU2174845C2 |
METHOD OF SUPPRESSION OF HIV-INFECTED MAMMALIAN CELLS AND PROTEIN RECOMBINANT RECEPTOR FOR ITS REALIZATION | 1995 |
|
RU2165703C2 |
ARTIFICIAL PROTEIN-IMMUNOGEN TCI COMPRISING MULTIPLE CTL-EPITOPES OF HIV-1 BASIC ANTIGENS, ARTIFICIAL GENE TCI ENCODING POLYEPITOPE PROTEIN-IMMUNOGEN TCI | 2002 |
|
RU2238946C2 |
HIV-1 SUBTYPE A P17 PROTEIN ANTIBODIES | 2019 |
|
RU2727673C1 |
SYNTHETIC GENE ENCODING GREEN FLUORESCENT PROTEIN, METHOD FOR PREPARING GENE, EXPRESSING VECTOR, METHOD FOR PREPARING CELL CULTURE | 1997 |
|
RU2233329C2 |
Authors
Dates
2007-12-20—Published
2002-09-18—Filed